HDAC9 and neoplasm: These data indicated that the single drug treatment groups did not reduce tumor growth while the ATRA and HDAC inhibitor (SAHA or romidepsin) in combination treatment synergistically inhibited tumor growth after 4 d of treatment (Figure S11B, Supporting Information, right).